vSpring Capital
VC Fund
Salt Lake City, United States
vSpring Capital is a VC fund in Salt Lake City focused on Software and Health Care. vSpring Capital and Signal Peak Ventures, both based in Salt Lake City, are combining as equal partners in a new investment firm that, effective immediately, will operate under the Signal Peak Ventures name, both companies announced Tuesday. No money was exchanged.vSpring is a traditional early-stage venture capital firm with over $350 millionof committed capital under management. Specifically, they target information technology and life sciences companies headquartered in the Intermountain West region. They look for companies with the potential to transform their markets and create lasting value. Their primary areas of focus include enterprise software, networking and communications, security software, Internet, mobile computing, drug discovery, drug delivery, diagnostics, and medical devices, all markets where the firm has deep experience.Their strategy is to be the first investor in these companies and to provide a level of operational assistance that creates additional value. They take a labor-intensive, service-oriented approach by making early introductions to key customers and strategic partners and helping to recruit top executives and co-investors.
- Total investments:
- 65
- Last investment:
- Lead investor:
- 32%
- Fund size:
- $13M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries vSpring Capital invests in
Stages vSpring Capital invests in
Countries vSpring Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
David Anderson
|
|||
|
Michael S. Paul
|
|||
|
|
Investment Focus
Industry
- Software 11 (17%)
- Health Care 10 (15%)
- Biotechnology 9 (14%)
- Medical 6 (9%)
- SaaS 4 (6%)
Stage
- Series B 24 (37%)
- Series A 19 (29%)
- Funding Round 6 (9%)
- Series C 5 (8%)
- Seed 2 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Dinesh Patel
Founding Managing Director
|
Founding Managing Director | Total investments: 4 | Find email | |
|
Brandon Tidwell
Founding Partner & Managing Director
|
Founding Partner & Managing Director | Total investments: 25 | Find email | |
|
David Anderson
CFO
|
CFO | Total investments: 0 | Find email | |
|
Michael S. Paul
Venture Partners
|
Venture Partners | Total investments: 0 | Find email | |
|
Michael S. Paul
Venture Partners
|
Venture Partners | Total investments: 0 | Find email | |
| See all 6 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Lineagen is a provider of diagnostic and healthcare services focused on complex diseases for which an individual's genetic profiles contribute strongly to their susceptibility. Lineagen is committed to improving outcomes for those affected by autism and other complex diseases, for which effective early diagnosis and intervention can have asignificant positive impact. The company's comprehensive genetic testing and support/counseling service are initially designed to enable early evaluation of children at risk for disorders of childhood development, including autism spectrum disorders (ASDs). Founded in 2002, Lineagen's commercial strategy represents the culmination of significant proprietary research into genetic causes and diagnostic pathways of key complex diseases, including autism, MS, and COPD. One of the company's core research competitive advantages is its access through the University of Utah to the Utah Population Database, an unmatched biomarker discovery research platform that has been used to help the University identify more disease-related genes than any other institution in the world. | $16M / Series B / Nov 04, 2011 | |
|
|
Radiate Media formerly Matchbin, provides software and services that empower local media and businesses to find and capture the audience that matters most. From local news, weather, and traffic information to online and broadcast marketing tools, Radiate Media’s technology and nationwide network allows clients to grow revenue by reaching customerson-air, online, and on the go. | $10M / Series B / Nov 01, 2011 | |
|
|
nanoMR has developed the first system for rapid isolation of rare cells from complex matrices at levels of 1 cell/mL or lower. The immunomagnetic capture system can target multiple cell types simultaneously, for example capturing bacteria and fungi from bloodstream infections, or specific cell types, such as circulating tumor, or fetal, cells,in less than 30 minutes. | $13M / Series B / Jul 19, 2011 | |
|
|
Control4 Corporation manufactures wired and wireless home automation products in the United States. It offers software and hardware products, which enable home theater and television, multi-room music, lighting, temperature, and security control through a range of in-home and over-the-Web remote control technology. The company's productsinclude wireless dimmers and switches, speakers, multi tuners, multi channel amplifiers, audio matrix switches, video switchers, and home entertainment and control systems. It also offers wireless thermostats, touch screens, keypads, controllers, contact/relay extenders, and system remote controls. The company sells its products through dealers in the United States, Canada, and internationally, as well as through custom integrators, distributors, and retail outlets. It serves consumer electronics companies, hotels, businesses, and utilities sector. Control4 Corporation has a strategic relationship with APOGEE Interactive. The company was founded in 2003 and is headquartered in Salt Lake City, Utah. | $15M / Feb 07, 2011 | |
|
|
Reachable helps teams create and leverage their collective rolodex to find referrals to business opportunities. Reachable enables everyone to consolidate all their contact data in their own contact database, enriches the data with data from Reachable's data partners, and analyzes the contact data to find referrals to sales targets. With thenew Reachable Teams, anyone can create a private network with people they trust, at work or in professional contexts, and leverage their Collective Rolodex. | $6.8M / Series A / Oct 13, 2010 | |
|
|
Lineagen is a provider of diagnostic and healthcare services focused on complex diseases for which an individual's genetic profiles contribute strongly to their susceptibility. Lineagen is committed to improving outcomes for those affected by autism and other complex diseases, for which effective early diagnosis and intervention can have asignificant positive impact. The company's comprehensive genetic testing and support/counseling service are initially designed to enable early evaluation of children at risk for disorders of childhood development, including autism spectrum disorders (ASDs). Founded in 2002, Lineagen's commercial strategy represents the culmination of significant proprietary research into genetic causes and diagnostic pathways of key complex diseases, including autism, MS, and COPD. One of the company's core research competitive advantages is its access through the University of Utah to the Utah Population Database, an unmatched biomarker discovery research platform that has been used to help the University identify more disease-related genes than any other institution in the world. | $10.8M / Series A / Aug 30, 2010 | |
|
|
The American Academy, Inc. (TAA) was established in 2007 with the vision is to become the leading online educational services partner to public high schools throughout the U.S.In addition to providing online and alternative educational services to high schools, TAA operates an accredited, private, online high school (The American Academy) thatserves high school age and adult students worldwide who want to supplement their high school education and/or earn a full high school diploma.Through its unique School-as-a-Serviceâ„¢ platform, The American Academy gives:Students an opportunity to choose from more than 230 online courses, supported by state-licensed teachers and access to tutoring 24/7.High Schools an innovative program for dropout recovery and prevention, as well as offering additional courses for credit recovery or curriculum expansion.Teachers the ability to teach, develop content, tutor and perform community outreach to promote online learning. | $5.9M / Series B / Dec 15, 2009 | |
|
|
Penguin Computing Inc. offers Linux software, systems, and services for high-performance computing (HPC) applications. The company specializes in cluster virtualization. It offers rackmount servers, HPC cluster systems and software, storage solutions, and Linux workstations; peripherals, data protection, cluster interconnects, infrastructuremanagement servers, and power management solutions; and Scyld ClusterWare HPC for the deployment and management of a Linux cluster. Penguin Computing Inc. also provides cluster delivery and orientation, onsite cluster assembly and installation, site planning and assessment, high performance computing consulting, and custom system deployment services. The company serves the high-performance computing, Web infrastructure, and enterprise computing areas in life science, aerospace, automotive, energy, government, and education markets. Penguin Computing Inc. was founded in 1998 and is headquartered in San Francisco, California. | $1.5M / Nov 09, 2009 | |
|
|
Coherex Medical, Inc. develops medical devices for addressing the structural heart disease conditions. It offers patent foramen ovale (PFO) closure system, which is designed to stimulate tissue in-growth to ensure long-term closure of the PFO. The company was founded as Proximare, Inc. in 2003 and changed its name to Coherex Medical, Inc. in2006. The company is based in Salt Lake City, Utah. | $16.5M / Series B / Oct 12, 2009 | |
|
|
Athena Feminine Technologies, Inc. develops health products to diagnose and treat medical conditions in the pelvic area in adult women in the United States. It offers Pelvic Muscle Trainer, a wireless electrical stimulation product that is developed to treat and prevent female incontinence. The company's products also detect and/orrehabilitate common physiological changes that occur in adult women. It primarily serves players, travelers, and celebrities. Athena Feminine Technologies, Inc. was incorporated in 1996 and is headquartered in Orinda, California. | $2M / Series A / Sep 02, 2009 | |
| See all 65 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does vSpring Capital invest in?
vSpring Capital invests primarily in Software, Health Care and Biotechnology startups, most often at Series B and Series A stage. Most of the 65 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact vSpring Capital?
Public channels for vSpring Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at vSpring Capital?
The team at vSpring Capital includes Dinesh Patel (Founding Managing Director), Brandon Tidwell (Founding Partner & Managing Director) and David Anderson (CFO), among 6 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!